Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer

Circular RNAs (circRNAs) are important regulators that drive or inhibit cancer initiation and development. Here, we identified the expression and function of a circRNA, circ_KIAA1199, in colorectal cancer (CRC). The expression levels of circ_KIAA1199, microRNA-34c-5p (miR-34c-5p) and Musashi RNA-bin...

Full description

Saved in:
Bibliographic Details
Published inAnti-cancer drugs Vol. 33; no. 1; p. e134
Main Authors Zhang, Yanbo, Yu, Hailong, Guo, Zhen
Format Journal Article
LanguageEnglish
Published England 01.01.2022
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Circular RNAs (circRNAs) are important regulators that drive or inhibit cancer initiation and development. Here, we identified the expression and function of a circRNA, circ_KIAA1199, in colorectal cancer (CRC). The expression levels of circ_KIAA1199, microRNA-34c-5p (miR-34c-5p) and Musashi RNA-binding protein 1 (MSI1) mRNA were detected by quantitative real-time PCR. Cell proliferative capacity was assessed by colony formation assay, EdU assay and MTT assay. Cell apoptosis was determined by flow cytometry assay. Cell migration and cell invasion were investigated by transwell assay. The expression of MSI1 protein and proliferation, migration-related markers was detected by western blot. The relationship between miR-34c-5p and circ_KIAA1199 or MSI1 was verified by dual-luciferase reporter assay. Animal models were constructed to ascertain the role of circ_KIAA1199 in vivo. The expression of circ_KIAA1199 was elevated in CRC. Circ_KIAA1199 downregulation suppressed CRC cell proliferation, survival, migration and invasion. MiR-34c-5p was a target of circ_KIAA1199. The effects of circ_KIAA1199 downregulation were reversed by miR-34c-5p deficiency. In addition, MSI1 was a target of circ_KIAA1199, and the inhibitory effects of miR-34c-5p restoration on CRC cell proliferation, survival, migration and invasion were reversed by MSI1 overexpression. Circ_KIAA1199 positively regulated MSI1 expression by targeting miR-34c-5p. Moreover, circ_KIAA1199 knockdown blocked tumor growth in animal models. Circ_KIAA1199 functioned as an oncogene to drive the malignant development of CRC by activating MSI1 via competitively targeting miR-34c-5p.
AbstractList Circular RNAs (circRNAs) are important regulators that drive or inhibit cancer initiation and development. Here, we identified the expression and function of a circRNA, circ_KIAA1199, in colorectal cancer (CRC). The expression levels of circ_KIAA1199, microRNA-34c-5p (miR-34c-5p) and Musashi RNA-binding protein 1 (MSI1) mRNA were detected by quantitative real-time PCR. Cell proliferative capacity was assessed by colony formation assay, EdU assay and MTT assay. Cell apoptosis was determined by flow cytometry assay. Cell migration and cell invasion were investigated by transwell assay. The expression of MSI1 protein and proliferation, migration-related markers was detected by western blot. The relationship between miR-34c-5p and circ_KIAA1199 or MSI1 was verified by dual-luciferase reporter assay. Animal models were constructed to ascertain the role of circ_KIAA1199 in vivo. The expression of circ_KIAA1199 was elevated in CRC. Circ_KIAA1199 downregulation suppressed CRC cell proliferation, survival, migration and invasion. MiR-34c-5p was a target of circ_KIAA1199. The effects of circ_KIAA1199 downregulation were reversed by miR-34c-5p deficiency. In addition, MSI1 was a target of circ_KIAA1199, and the inhibitory effects of miR-34c-5p restoration on CRC cell proliferation, survival, migration and invasion were reversed by MSI1 overexpression. Circ_KIAA1199 positively regulated MSI1 expression by targeting miR-34c-5p. Moreover, circ_KIAA1199 knockdown blocked tumor growth in animal models. Circ_KIAA1199 functioned as an oncogene to drive the malignant development of CRC by activating MSI1 via competitively targeting miR-34c-5p.
Author Yu, Hailong
Zhang, Yanbo
Guo, Zhen
Author_xml – sequence: 1
  givenname: Yanbo
  surname: Zhang
  fullname: Zhang, Yanbo
  organization: Department of General Surgery, Liaocheng People's Hospital, Liaocheng City, Shandong Province, China
– sequence: 2
  givenname: Hailong
  surname: Yu
  fullname: Yu, Hailong
– sequence: 3
  givenname: Zhen
  surname: Guo
  fullname: Guo, Zhen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34387591$$D View this record in MEDLINE/PubMed
BookMark eNpNkN1KxDAUhIMo6qpvIHJeoGtPk27by2X9W1QEf66Xk-S0G2mTJY2Kz-BLu6CCczMDHzMXMxG7PngW4hTzKeZNdb6YX0zzf0KcqR1xiKqSWVkpPBCTcXzdgm2W--JAKllXZYOH4mvholndLudzxKYB59dOuzTC_dMSwXIXyVJywYP-hESx4-R8B4N7zKQyWbmBFMBG986Q1gwD9a7z5BMY7nvQvKZ3F-II5C2ktyFE6GL4SGsILZjQh8gmUQ-GvOF4LPZa6kc--fUj8XJ1-by4ye4erpeL-V1mZFlgpjRJ1SKqmdK1rm1hyoJtW-e5sTSjmprKsqKCJaPGBlUpsVXbRsFtyZqKI3H2s7t50wPb1Sa6geLn6u-V4hvvtGWX
CitedBy_id crossref_primary_10_3389_fimmu_2023_1222425
crossref_primary_10_1002_ptr_7863
crossref_primary_10_1007_s12033_024_01167_w
crossref_primary_10_1016_j_prp_2023_154592
crossref_primary_10_52756_ijerr_2024_v45spl_022
ContentType Journal Article
Copyright Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/CAD.0000000000001164
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1473-5741
ExternalDocumentID 34387591
Genre Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
0R~
23M
4Q1
4Q2
4Q3
53G
5GY
5VS
6J9
71W
8L-
AAAAV
AAHPQ
AAIQE
AAMTA
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADGGA
ADHPY
AE3
AE6
AENEX
AFDTB
AGINI
AHQNM
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BQLVK
C45
CGR
CS3
CUY
CVF
DIWNM
E.X
EBS
ECM
EEVPB
EIF
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
KD2
L-C
N9A
NPM
O9-
OAG
OAH
ODA
OLG
OLW
OPC
OPUJH
OVD
OVDNE
OWV
OWW
OWY
OWZ
OXXIT
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
ZFV
ID FETCH-LOGICAL-c3521-4ba34f11464b8b8d2c52edf800cda6a8a97de4a2e3e1b1914531f44f12ef5eba2
IngestDate Wed Feb 19 02:27:28 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3521-4ba34f11464b8b8d2c52edf800cda6a8a97de4a2e3e1b1914531f44f12ef5eba2
PMID 34387591
ParticipantIDs pubmed_primary_34387591
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Anti-cancer drugs
PublicationTitleAlternate Anticancer Drugs
PublicationYear 2022
SSID ssj0007413
Score 2.3552318
Snippet Circular RNAs (circRNAs) are important regulators that drive or inhibit cancer initiation and development. Here, we identified the expression and function of a...
SourceID pubmed
SourceType Index Database
StartPage e134
SubjectTerms Animals
Apoptosis - drug effects
Cell Line, Tumor
Cell Movement - drug effects
Cell Proliferation - drug effects
Colorectal Neoplasms - pathology
Down-Regulation - drug effects
Female
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
MicroRNAs - drug effects
Nerve Tissue Proteins - drug effects
RNA, Circular - pharmacology
RNA-Binding Proteins - drug effects
Tumor Burden
Xenograft Model Antitumor Assays
Title Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/34387591
Volume 33
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELa6IK32gmB5vzQHtJeuAcdOmhyjBbQLKlpBV1q4VHZsbyPRpCrpofwF-NGM4zzaZUFAD1Flp1bb79N4ZjLzmZBnSvMoiRmjVoWWOkUqGmtlqUw4om0znVnXjTx-Hx2fibfn4flg8GOjamlVqefZtyv7Sv4HVRxDXF2X7D8g2y2KA_ge8cUrIozXv8L4KF9m03cnacpYkgzzYpYr9xxg_PGEDbVTgfAHJtUuZl3x7fIC8_wD5SKj4cL5nXrpSoec9zlHj_zClcUMXTK_69_3Gs7Val4uhxcYs1czX4mOcT7aSqcu4niz3HRy06LKqR_G9Vd9Jr7LTn-ShSo7g7Oq9z-ZfymbbdTVA63qHO7nWdOq1iQmgmAjMWG8MRUjTsORF7Zqra2XvdhilTedhvms5i82vdEKTl95rcnmxVi0dTsis5jXOHPBMQjzZ4D9efaS0nY7tUN2MOZwh6i6zE-zq-PP4G3rZTJ6cdXX2SO77RKXgpTaWZncJDeaKANST5lbZGCKfbI7buoo9snBqVcsXx_CpG_A-3oIB3Daa5mvb5PvWxSDlmLgKAYbFAO1ho5i0FMMqhJqigFSDDqKgaMYdBQDpBjUFANPMSgt9BQDz6U75OzN68nRMW3O76AZuvWMCiW5sK7tXahYxTrIwsBoiyFKpmUkY5mMtBEyMNww5XQGcT-wAj8RGBsaJYO75FpRFuY-AWGzSEkZJC-1QoPCZaYF3oKxjbRGcf2A3PP_93ThRVqmLRIPfzvziOz1tH1Mrlu0CuYJupiVelpj_xNL83uL
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circ_KIAA1199+inhibits+MSI1+degradation+by+targeting+miR-34c-5p+to+drive+the+malignant+cell+behaviors+and+tumor+growth+of+colorectal+cancer&rft.jtitle=Anti-cancer+drugs&rft.au=Zhang%2C+Yanbo&rft.au=Yu%2C+Hailong&rft.au=Guo%2C+Zhen&rft.date=2022-01-01&rft.eissn=1473-5741&rft.volume=33&rft.issue=1&rft.spage=e134&rft_id=info:doi/10.1097%2FCAD.0000000000001164&rft_id=info%3Apmid%2F34387591&rft_id=info%3Apmid%2F34387591&rft.externalDocID=34387591